Krebs Biochemicals & Industries (BOM:524518) Cash-to-Debt : 0.02 (As of Mar. 2024)

View and export this data going back to 2000. Start your Free Trial

What is Krebs Biochemicals & Industries Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Krebs Biochemicals & Industries's cash to debt ratio for the quarter that ended in Mar. 2024 was 0.02.

If Cash to Debt ratio is less than 1, the company cannot pay off its debt using the cash in hand. Here we can see, Krebs Biochemicals & Industries couldn't pay off its debt using the cash in hand for the quarter that ended in Mar. 2024.

The historical rank and industry rank for Krebs Biochemicals & Industries's Cash-to-Debt or its related term are showing as below:

BOM:524518' s Cash-to-Debt Range Over the Past 10 Years
Min: 0 Med: 0.01 Max: 0.42
Current: 0.02

During the past 13 years, Krebs Biochemicals & Industries's highest Cash to Debt Ratio was 0.42. The lowest was 0.00. And the median was 0.01.

BOM:524518's Cash-to-Debt is ranked worse than
95.32% of 1047 companies
in the Drug Manufacturers industry
Industry Median: 0.93 vs BOM:524518: 0.02

Krebs Biochemicals & Industries Cash-to-Debt Historical Data

The historical data trend for Krebs Biochemicals & Industries's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Krebs Biochemicals & Industries Cash-to-Debt Chart

Krebs Biochemicals & Industries Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Cash-to-Debt

Get a 7-Day Free Trial

0.01

0.02

Krebs Biochemicals & Industries Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Cash-to-Debt	Get a 7-Day Free Trial															-	N/A	0.01	N/A	0.02

Competitive Comparison of Krebs Biochemicals & Industries's Cash-to-Debt

For the Drug Manufacturers - Specialty & Generic subindustry, Krebs Biochemicals & Industries's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Krebs Biochemicals & Industries's Cash-to-Debt Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Krebs Biochemicals & Industries's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Krebs Biochemicals & Industries's Cash-to-Debt falls into.

Krebs Biochemicals & Industries Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Krebs Biochemicals & Industries's Cash to Debt Ratio for the fiscal year that ended in Mar. 2024 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	31.503	/	(99.295	+	1835)
	=	0.02

Krebs Biochemicals & Industries's Cash to Debt Ratio for the quarter that ended in Mar. 2024 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	31.503	/	(99.295	+	1835)
	=	0.02

Krebs Biochemicals & Industries (BOM:524518) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

Krebs Biochemicals & Industries Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Krebs Biochemicals & Industries's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Krebs Biochemicals & Industries (BOM:524518) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Krebs Biochemicals & Industries Ltd (BOM:524518) » Definitions » Cash-to-Debt

Traded in Other Exchanges

KREBSBIO:India

Address

Road No. 8, Banjara Hills, 8-2-577/B, Plot No. 34, 3rd Floor, Maas Heights, Hyderabad, TG, IND, 500 034

Website

http://www.krebsbiochem.com

Krebs Biochemicals & Industries Ltd is a biochemical company in India. It is engaged in the business of manufacture of active pharmaceutical ingredients. It has two manufacturing plants in Andhra Pradesh, India - one in Nellore and one in Vizag both Units are equipped for chemical synthesis, fermentation, and enzymatic technologies providing Krebs with production capacity.

Krebs Biochemicals & Industries (BOM:524518) Headlines

No Headlines